Histologically or cytologically confirmed adenocarcinoma of the pancreas [clinicaltrials_resource:3cd1c97fe3cedf86dfefa9c64c2e8622]
eligibility for clinicaltrials:NCT00057876 [clinicaltrials_resource:49cef2bd6d77f2df12cfbafa0257c628]eligibility for clinicaltrials:NCT01822756 [clinicaltrials_resource:8333e2966be00fc2d2def9bc6efa7675]eligibility for clinicaltrials:NCT00585078 [clinicaltrials_resource:aabcc399e76603c5e2dc9ab1a0384e54]eligibility for clinicaltrials:NCT01956812 [clinicaltrials_resource:bb8d79a0c623c2695fb60c344ebd567b]eligibility for clinicaltrials:NCT01897454 [clinicaltrials_resource:daf2d4d2378d0880c85300ec36ba58f8]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT00047307 [clinicaltrials_resource:3b8a5410e3b8c789f9a2af6ddb44c4fc]eligibility for clinicaltrials:NCT00057876 [clinicaltrials_resource:49cef2bd6d77f2df12cfbafa0257c628]eligibility for clinicaltrials:NCT00085371 [clinicaltrials_resource:5085fe971652de68179f509f20b920a7]eligibility for clinicaltrials:NCT00735917 [clinicaltrials_resource:6426f73d7e97ea053f384adaa0b1bf3b]eligibility for clinicaltrials:NCT01822756 [clinicaltrials_resource:8333e2966be00fc2d2def9bc6efa7675]eligibility for clinicaltrials:NCT00075647 [clinicaltrials_resource:a03614566d6718061441c54c9b3487fe]eligibility for clinicaltrials:NCT00095966 [clinicaltrials_resource:a8429792ef36ace48a423cef749d1e98]eligibility for clinicaltrials:NCT00585078 [clinicaltrials_resource:aabcc399e76603c5e2dc9ab1a0384e54]eligibility for clinicaltrials:NCT00288093 [clinicaltrials_resource:ab72c14fdcee81fe3f19548fdf41e3ec]eligibility for clinicaltrials:NCT00063947 [clinicaltrials_resource:b84328e5a04b70eb75e0b5991a80c92d]eligibility for clinicaltrials:NCT00091026 [clinicaltrials_resource:b8fed00f3841fb7ded13b537ee0798a0]eligibility for clinicaltrials:NCT01956812 [clinicaltrials_resource:bb8d79a0c623c2695fb60c344ebd567b]eligibility for clinicaltrials:NCT00331682 [clinicaltrials_resource:c8322dc2060a312aac51c3ffe3b8b2f8]eligibility for clinicaltrials:NCT01897454 [clinicaltrials_resource:daf2d4d2378d0880c85300ec36ba58f8]eligibility for clinicaltrials:NCT00474812 [clinicaltrials_resource:e4c3b3caa0eba00f7dbde71c603db4b7]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Histologically or cytologically confirmed adenocarcinoma of the pancreas [clinicaltrials_resource:3cd1c97fe3cedf86dfefa9c64c2e8622]
Bio2RDF identifier
3cd1c97fe3cedf86dfefa9c64c2e8622
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3cd1c97fe3cedf86dfefa9c64c2e8622
identifier
clinicaltrials_resource:3cd1c97fe3cedf86dfefa9c64c2e8622
title
Histologically or cytologically confirmed adenocarcinoma of the pancreas
@en
type
label
Histologically or cytologicall ...... 1c97fe3cedf86dfefa9c64c2e8622]
@en